Prostate Cancer Imaging Beyond PSMA: Applications of GRPR, AR, and Amino Acid Tracers. [PDF]
Ali FZ.
europepmc +1 more source
Butylated Neuropeptide Antagonist Targeting Hypoxia-Induced GRPR Overexpression in Small Cell Lung Cancer. [PDF]
Deureh S +5 more
europepmc +1 more source
Improving GRPR-targeting peptides for radiotheranostics application: insights from chelator modifications and α-methyl-L tryptophan substitution. [PDF]
Obeid K +4 more
europepmc +1 more source
Decoding GPCR signaling reprogramming in cancer: molecular mechanisms and therapeutic implications. [PDF]
Aldeyarbi S +4 more
europepmc +1 more source
The Impact of the Injected Mass of the Gastrin-Releasing Peptide Receptor Antagonist on Uptake in Breast Cancer: Lessons from a Phase I Trial of [<sup>99m</sup>Tc]Tc-DB8. [PDF]
Bragina O +13 more
europepmc +1 more source
Peptide receptor radionuclide therapy in neuroendocrine tumours: advances, combination strategies, and future directions. [PDF]
Virgolini IJ, Di Santo G, Santo G.
europepmc +1 more source
Discovery of a Potent Small Molecule Antagonist of GRPR for the Treatment of Pruritus. [PDF]
Zhou M +13 more
europepmc +1 more source
The role of naturally-occurring canine tumors in translating conserved consequences of epithelial-mesenchymal plasticity to human cancers. [PDF]
Bakhle KM, Dongre A.
europepmc +1 more source
The neuro-immune insights of itch: peripheral mechanisms and central glial contributions. [PDF]
Li Z +5 more
europepmc +1 more source
Emerging PET Imaging Agents and Targeted Radioligand Therapy: A Review of Clinical Applications and Trials. [PDF]
Palihati M, Das JP, Yeh R, Capaccione K.
europepmc +1 more source

